Michael Barone is a senior political analyst for the Washington Examiner, resident fellow at the American Enterprise Institute and longtime co-author of The Almanac of American Politics.
Was it just a coincidence that Vice President Kamala Harris showed up, 15 minutes late, to be interviewed by Fox News anchor Bret Baier a day before Nate Silver’s poll aggregation website showed her chances of winning the election slipping below 50%? Probably not.
What may link Harris’ slide in the polls and her tardy appearance for an interview in which she served up word salads to Baier’s questions on illegal immigration and inflation and then segued, sometimes awkwardly, to denunciations of former President Donald Trump?
October hasn’t been a good month for Harris or her party.
Nor has it been an entirely bad one. Silver’s model still gives her a 47% chance of winning, much higher than Trump’s 29% on election eve 2016. But it’s perceptibly below her 57% chance Sept. 27, which reflected poll results after the Sept. 10 debate. […]
— Read More: www.dailysignal.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
